期刊文献+

戒酒与药物治疗对酒精性肝纤维化作用的临床研究 被引量:2

下载PDF
导出
摘要 目的观察戒酒治疗与单纯药物治疗对酒精性肝纤维化的疗效比较。方法酒精性肝纤维化患者100例随机分为戒酒治疗组和药物治疗组(未彻底戒酒),每组50例,观察治疗前、后肝纤维化指标(HA、LN、PC-Ⅲ、Ⅳ-C)、肝功能的变化。结果治疗后2组各项指标均较治疗前有明显改善(P<0.05),但是戒酒治疗组下降幅度优于药物治疗组(P<0.05)。结论针对酒精性肝纤维化,戒酒治疗尤为重要,是决定预后的关键因素。
出处 《河北医药》 CAS 2009年第10期1205-1206,共2页 Hebei Medical Journal
  • 相关文献

参考文献4

二级参考文献41

  • 1杨一林,曹铁生,段云友,阮骊韬,陈升,刘禧,王泓.超声检测肝循环指数改变对纤维化肝储备功能的实验研究[J].中国超声医学杂志,2005,21(6):410-412. 被引量:4
  • 2Grant BF,Dufour MC,Harford TC.Epidemiology of alcoholic liver disease[ J ].Semin Liver Dis,1988,8 (1):12-25.
  • 3Becker U,Deis A,Sorensen TI,et al.Prediction of risk of liver disease by alcohol intake,sex,and age:a prospective population study[ J ].Hepatology,1996,23 (5):1025 -1029.
  • 4Pares A,Barrera JM,Caballeria J,et al.Hepatitis C virus antibodies in chronic alcoholic patients:association with severity of liver injury[ J ].Hepatology,1990,12 (6):1295-1299.
  • 5Sorensen TIA.Alcohol and liver injury:dose-related or permissive effect ?[J] Liver,1989,9(4):189-197.
  • 6Akriviadis E,Botla R,Briggs W,et al.Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis:a doubleblind,placebo controlled trial[ J ].Gastroenterology,2000,119(6):1637-1648.
  • 7Mutimer DJ,Burra P,Neuberger JM,et al.Managing severe alcoholic hepatitis complicated by renal failure[ J ].Q J Med,1993,86(10):649-656.
  • 8Lieber CS.Biochemical factors in alcoholic liver disease[ J].Semin Liver Dis,1993,13 (2):136-153.
  • 9Meagher EA,Barry OP,Burke A,et al.Alcohol-induced generation of lipid peroxidation products in humans[J].J Clin Invest,1999,104(6):805 -813.
  • 10Arteel GE.Oxidants and antioxidants in alcohol-induced liver disease[ J].Gastroenterology,2003,124 (3):778-790.

共引文献11

同被引文献33

  • 1尹珊珊,王宝恩,王泰龄,贾继东,钱林学.复方861治疗慢性乙型肝炎肝纤维化与早期肝硬化的临床研究[J].中华肝脏病杂志,2004,12(8):467-470. 被引量:81
  • 2陈孝银,李恩庆,沈强,章群,孙立,徐云生.大黄虫庶虫丸抑制乙型肝炎后肝纤维化的临床研究[J].中国病理生理杂志,2005,21(5):1018-1019. 被引量:14
  • 3Tonnesen H.Alcohol abuse and postoperative morbidity[J].Dan Med Bull,2003,50(2):139-160.
  • 4Chung F,Mezei G,Tong D.Pre-existing medical conditions as predictors of adverse events in day-case surgery[J].Br Anaesth,1999,83(1):262-270.
  • 5Spies C,Tonnesen H,Andreasson S,et al.Perioperative morbidity and mortality in chronic alcoholic patients[J].Alcohol Clin Exp Res,2001,25(4):164s-170s.
  • 6慢性病危险因素阶梯式监测(STEPS)问卷及调查指南[S].日内瓦,世界卫生组织,2005.
  • 7World Health Organization.International guide for monitoring alcohol consumption and related harm[S].Geneva:WHO,2000.
  • 8Cooperative Group of China Obesity Task Force.Guidelines for prevention and control of overweight and obesity in Chinese adults[J].Acta Nutri Sinica,2004,26(1):1-4(in Chinese).
  • 9Zevin S,Benowitz NL.Drug interactions with tobacco smoking[J].Anupdate Clin Pharmacokinet,1999,36(2):425-438.
  • 10Sorensen LT,Jorgensen T,Kirkeby LT,et al.Smoking and alcohol abuse are major risk factors for anastomotic leakage in colorectal surgery[J].Br J Surg,1999,86(5):927-931.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部